Recent advances in redox proteomics have identified novel biomarkers like peroxiredoxin-3 oxidation that predict neuropathy progression 5 years before clinical onset ( 7 Clinical trial protocol design for antioxidant therapy in hypertension and diabetes The selection of appropriate OS biomarkers is critical for assessing the efficacy of antioxidant therapies employed in the treatment of HTN and DM from the results of clinical trials
Se consider como criterio principal de valoracin combinado a la aparicin de eventos renales graves (necesidad de terapia de re emplazo renal, mortalidad por causa renal, hospitalizacin por eventos renales)
Use targeted supplements if needed to rebuild reserves
Hankosky ER, Chinthammit C, Meeks A, Huang A, Ward JM, Mojdami D, Gibble TH
1 More thyroxine in your system lowers how much levothyroxine you need, just as weight loss does